Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. by Lutgendorff, F. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/183595
 
 
 
Please be advised that this information was generated on 2018-04-11 and may be subject to
change.
Probiotics Prevent Intestinal Barrier Dysfunction in Acute
Pancreatitis in Rats via Induction of Ileal Mucosal
Glutathione Biosynthesis
Femke Lutgendorff1,2, Rian M. Nijmeijer2, Per A. Sandstro¨m1, Lena M. Trulsson1, Karl-Eric Magnusson3,
Harro M. Timmerman2, L. Paul van Minnen2, Ger T. Rijkers2, Hein G. Gooszen2, Louis M. A. Akkermans2,
Johan D. So¨derholm1*
1Department of Clinical and Experimental Medicine, Division of Surgery, Linko¨ping University, Linko¨ping, Sweden, 2Gastrointestinal Research Unit, Department of
Surgery, University Medical Center, Utrecht, the Netherlands, 3Department of Clinical and Experimental Medicine, Division of Medical Microbiology, Linko¨ping University,
Linko¨ping, Sweden
Abstract
Background: During acute pancreatitis (AP), oxidative stress contributes to intestinal barrier failure. We studied actions of
multispecies probiotics on barrier dysfunction and oxidative stress in experimental AP.
Methodology/Principal Findings: Fifty-three male Spraque-Dawley rats were randomly allocated into five groups: 1)
controls, non-operated, 2) sham-operated, 3) AP, 4) AP and probiotics and 5) AP and placebo. AP was induced by intraductal
glycodeoxycholate infusion and intravenous cerulein (6 h). Daily probiotics or placebo were administered intragastrically,
starting five days prior to AP. After cerulein infusion, ileal mucosa was collected for measurements of E. coli K12 and 51Cr-
EDTA passage in Ussing chambers. Tight junction proteins were investigated by confocal immunofluorescence imaging.
Ileal mucosal apoptosis, lipid peroxidation, and glutathione levels were determined and glutamate-cysteine-ligase activity
and expression were quantified. AP-induced barrier dysfunction was characterized by epithelial cell apoptosis and
alterations of tight junction proteins (i.e. disruption of occludin and claudin-1 and up-regulation of claudin-2) and correlated
with lipid peroxidation (r.0.8). Probiotic pre-treatment diminished the AP-induced increase in E. coli passage (probiotics
57.4633.5 vs. placebo 223.7693.7 a.u.; P,0.001), 51Cr-EDTA flux (16.7610.1 vs. 32.1610.0 cm/s1026; P,0.005), apoptosis,
lipid peroxidation (0.4260.13 vs. 1.6260.53 pmol MDA/mg protein; P,0.001), and prevented tight junction protein
disruption. AP-induced decline in glutathione was not only prevented (14.3361.47 vs. 8.8261.30 nmol/mg protein,
P,0.001), but probiotics even increased mucosal glutathione compared with sham rats (14.3361.47 vs. 10.7061.74 nmol/
mg protein, P,0.001). Glutamate-cysteine-ligase activity, which is rate-limiting in glutathione biosynthesis, was enhanced in
probiotic pre-treated animals (probiotics 2.8861.21 vs. placebo 1.9460.55 nmol/min/mg protein; P,0.05) coinciding with
an increase in mRNA expression of glutamate-cysteine-ligase catalytic (GCLc) and modifier (GCLm) subunits.
Conclusions: Probiotic pre-treatment diminished AP-induced intestinal barrier dysfunction and prevented oxidative stress
via mechanisms mainly involving mucosal glutathione biosynthesis.
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Introduction
Multi-organ-failure and systemic inflammatory response syn-
drome (SIRS) remain major causes of mortality at intensive care
units [1]. There is compelling evidence for an important role of the
gut in the origin and development of critical illness [2,3]. Gut
barrier dysfunction can propagate a pathophysiological state
leading to increased mortality. Deitch et al. [4] demonstrated for
example, that shock-induced intestinal hypoperfusion leads to
release of reactive oxygen species (ROS) and oxidative stress
resulting in barrier failure and release of pro-inflammatory
mediators, enhancing a subsequent SIRS. Evidence suggests that
ROS disrupt epithelial tight junctions (TJs) [5,6] leading to barrier
dysfunction [7]. Furthermore, ROS cause epithelial cell apoptosis
[8] contributing to mucosal barrier failure [9–11] and associated
mortality [12,13] in experimental studies. Moreover, clinical
evidence shows that increased intestinal apoptosis is a prominent
event in patients who succumb from sepsis [14]. The mucosal
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barrier may be further compromised by overgrowth of enteric
pathogens e.g. Escherichia coli [15] or by other opportunistic
pathogens which switch on their virulence genes upon intestinal
hypoxia [16], suggesting an important role for intestinal microbiota
in gut-derived sepsis [2]. Taken together in critically ill patients,
SIRS may be driven by an oxidative stress-induced disruption of the
equilibrium of the otherwise symbiotic three-way partnership
between intestinal microbiota, epithelium, and immune system.
Conversely, a moderate increase in intracellular ROS concen-
trations may paradoxically afford protection against oxidative
stress via upregulation of oxidative defense mechanisms. Indeed, de
novo synthesis of the most important endogenous antioxidant,
glutathione (GSH) is found to be enhanced after low dose H2O2
[17] and is also increased by other weak oxidative agents [18].
Severe acute pancreatitis (AP), which is characterized by intestinal
barrier dysfunction and not seldom leading to SIRS, represents a
clinical disease in which maintenance of this equilibrium is severely
disturbed [3]. Since commensal bacteria are believed to be a crucial
part of host homeostasis, recent studies have looked at effects of
probiotics in recreating equilibrium [19–21]. Our group previously
developed a probiotic combination designed to prevent infectious
complications in critical illness based on anti-inflammatory and
microbiota modulating capacities [22]. Five-day pre-treatment with
these multispecies probiotics attenuated bacterial translocation and
reduced the mortality in experimental AP in rats [23], but recently
we also demonstrated in a double-blind clinical study that these
probiotics, contrary to any expectations, doubled the mortality
compared with placebo in 298 patients with predicted severe AP
[24]. These results painfully showed the need to study mechanisms
of action of probiotics in critical illnesses. The objective of this study
was to characterize the intestinal mucosal barrier in experimental
AP and to explore mechanisms by which multispecies probiotics
affect barrier function under these circumstances. We found that
probiotics maintained the mucosal barrier in AP by up-regulation of
the rate-limiting step in glutathione (GSH) biosynthesis.
Materials and Methods
Rats
Male specific pathogen-free Sprague-Dawley rats (B&K,
Sollentuna, Sweden, 250–350 g, 50–70 days of age) were
maintained under constant conditions with a 12-hour light/dark
cycle and free access to water and standard rat pellets. Rats were
acclimatized for one week prior to surgery and randomly allocated
into five groups: 1) non-operated controls (n = 5); 2) sham-
procedure (n = 12); 3) AP (n= 12); 4) AP, placebo (n= 12); 5)
AP, probiotics (n = 12). The experimental design (fig 1) was in
accordance with guidelines of the Linko¨ping University Animal
Welfare Committee, following European legislation (2003/65/
EC).
Probiotics
The multispecies probiotics consisted of six viable, freeze-dried
strains: Lactobacillus acidophilus (W70), Lactobacillus casei (W56),
Lactobacillus salivarius (W24), Lactococcus lactis (W58), Bifidobacterium
bifidum (W23), and Bifidobacterium lactis (W52) (previously classified
as Bifidobacterium infantis) (EcologicH 641, Winclove Bio Industries,
Amsterdam, the Netherlands). Placebo, that consisted of the
carrier of the probiotic product, i.e. cornstarch and maltodextran,
was packed in identical coded sachets to guarantee blinding.
Before daily administration, probiotic or placebo formulas were
reconstituted in sterile water, for 15 min at 37uC. A single
probiotic dose of 1.0 ml contained 56109 colony forming units
(CFU) of bacteria.
Surgical procedures
Under general anesthesia (2% isoflurane), a permanent gastric
cannula was fitted in all rats, as performed previously [23].
Animals were allowed to recover for four days prior to the start of
daily probiotics or placebo administrations through the cannula
and then after five days of pre-treatment AP was induced as
described by Schmidt et al. [25]. Briefly, pressure controlled
(35,mmHg) retrograde infusion of 0.5 ml sterilized glycodeoxy-
cholic acid (Sigma-Aldrich, Zwijndrecht, the Netherlands) into the
biliopancreatic duct was followed by intravenous cerulein (5 mg/
kg/h, 1 ml/h, for 6 h, Sigma-Aldrich). During the sham
procedure, cannulation of the biliopancreatic duct without
infusion of glycodeoxycholic acid was followed by intravenous
saline (1 ml/h, 6 h). Three animals needed to be excluded due to
detachment of the gastric cannula and two due to anaesthesiolo-
gical failures.
Figure 1. Experimental design. At the start of the experiment, animals were fitted with a gastric cannula, except for control animals. Probiotics
and placebo were administered daily to the probiotics and placebo group, starting 5 days prior to induction of acute pancreatitis (AP). At day 0, AP or
sham-procedure was performed. After the six hours of cerulein infusion, animals were anesthetized for removal of organ samples.
doi:10.1371/journal.pone.0004512.g001
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Collection of samples
Whole blood was sampled by tail vein puncture, before start of
treatment and before induction of acute pancreatitis. After
cerulein or saline infusion, rats were anaesthetized and 15 cm
distal ileum, the pancreatic tail and whole blood were collected.
Ten cm of ileum was used for Ussing chamber experiments and
immediately submersed into ice-cold oxygenated Kreb’s buffer
(115 mM NaCl, 1.25 mM CaCl2, 1.2 mM MgCl2, 2 mM
KH2PO4, and 25 mM NaHCO3, pH 7.35). The remainder was
flushed with cold Kreb’s buffer to remove adherent bacteria,
stripped of the external muscle, freeze-dried and stored at 270uC
until analyzed. Histological assessment verified that no bacteria
remained associated with the tissue samples. Samples for
histological and immunohistochemical examinations were forma-
lin fixed, and embedded in optimum cutting temperature
compound (Histolab, Va¨stra Fro¨lunda, Sweden). All analyses were
run in duplicates.
Ussing chamber experiments
Mucosal permeability was measured as previously described
[26]. Briefly, ileum, stripped of external muscle while immersed in
Kreb’s buffer, was mounted into Ussing chambers (Harvard
Apparatus Inc., Holliston, MA, USA [27]) where 9.6 mm2 tissue
was exposed to 3 ml (1.5 ml each half-chamber) circulating,
oxygenated Kreb’s solution at 37uC. The serosal buffer contained
10 mM glucose as energy source and was osmotically balanced by
10 mM mannitol in the mucosal buffer. Chambers contained
agar-salt bridges to monitor potential difference across the tissue
for vitality assessment. Baseline values for short circuit current
(Isc), indicating net ion secretion, and conductance (passive ion
flux), were recorded at equilibrium, 40 min after mounting.
Transepithelial transport of macromolecules was assessed by
measuring horseradish peroxidase (HRP) (Sigma-Aldrich), as
model antigen, and 51Cr-EDTA (Perkin-Elmer, Boston, MA,
USA) flux, as paracellular probe. HRP and 51Cr-EDTA were
added to the mucosal side to a final concentration of 1025 M and
34 mCi/ml, respectively. Serosal samples (300 ml) were collected at
0, 30, 60, 90 and 120 min after start and were used to analyze
transepithelial fluxes of 51Cr-EDTA, expressed as cm/s?1026,
using a gamma-counter (1282 Compugamma, LKB, Bromma,
Sweden). HRP-activity was determined as previously described
[26], and transepithelial HRP flux was expressed as
pmol?cm22?h21. Permeability was calculated in 3 ileal samples
per rat during the 30–120 min period for both markers.
To assess bacterial passage, fluorescent E.coli K12 (16108 CFU/
ml, Molecular Probes, Leiden, the Netherlands), killed by
paraformaldehyde to stop reproduction without loss of antigenicity
[28], were added after equilibration, to the mucosal side. After
120 min, the entire volume of serosal compartments was analyzed
at 488 nm in a fluorimeter (Cary Eclipse, Varian, Victoria,
Australia). One unit corresponds to 3.0?103 CFU/ml [26].
Immunohistochemistry
Frozen ileum sections (5 mm) of 4 rats per group were incubated
with 5% bovine serum albumin, washed and incubated with a
primary antibody (1:50 rabbit anti-rat occludin, mouse anti-rat
claudin-1 or mouse anti-rat claudin-2; Zymed Laboratories, San
Francisco, CA, USA) for 1 h at room temperature. Following
extensive washes, slides were incubated with Alexa FluorH488 goat
anti-mouse or anti-rabbit immunoglobulin-G (1:500 dilution,
Jackson ImmunoResearch Europe Ltd, London, United King-
dom) for 1 h at room temperature.
Apoptotic cells were detected by ‘in-situ cell death detection kit’
(Roche Diagnostics, Bromma, Sweden). Frozen ileum sections
(5 mm) were permeabilized in 0.1 mol/l sodium citrate for 2 min
on ice and incubated in terminal-deoxynucleotidyl-transferase-
mediated-dUTP-nick-end-labeling (TUNEL) reaction mixture for
1 h at 37uC.
All sections were counterstained with 0.5 mM 49,6-diamidineo-
2-phenylindole (DAPI) for 10 min, mounted in antifading
Fluorescent Mounting Medium (DakoCytomation, Stockholm,
Sweden) and examined using confocal imaging with a 2-photon
BioRad Radiance 2000 microscope (Carl Zeiss, Jena, Germany),
equipped with high numerical aperture (NA=1.4) 606and 1006
oil immersion objectives. Each test included negative controls.
Image acquisition settings were identical for each experiment.
Apoptotic rate was determined by counting the number of
TUNEL+ cells/100 epithelial cells in 4 sections from 4 rats per
group.
DNA-fragmentation assay
Histone-associated DNA-fragmentation was determined in ileal
homogenate corresponding to 50 mg freeze-dried mucosa as
previously described [29], using Cell Death Detection ELISA
PLUS (Roche Diagnostics). Results are normalized to protein
content, as measured according to Bradford’s method [30] and
expressed as ratio to control animals.
Histological measurements of mucosal damage
Coded ileal sections were haematoxylin-eosin (H&E) stained
and the degree of mucosal damage was determined in 4 tissue
sections per rat, by a pathologist blinded to the experimental
design. Histopathological grading, from 0 (normal mucosa) to 5
(severe mucosal damage), was performed according to criteria by
Chiu et al. [31].
To confirm pancreatitis, histological analysis of H&E stained
pancreatic sections was performed in 4 tissue sections per rat,
utilizing Spormann’s criteria [32].
Lipid peroxidation
To assess oxidative damage, malondialdehyde (MDA) concen-
tration was determined, using a lipid peroxidation assay (LPO-
586; Byoxitech, OXIS International, Portland, OR, USA). Ileal
mucosa was homogenized in 5 mM butylated hydroxytoluene to
prevent sample oxidation. Supernatants were used to determine
MDA levels according to manufacturer’s instructions. Results were
normalized to protein contents of the crude homogenates.
Glutathione assay
To estimate the antioxidative capacity, reduced and oxidized
GSH contents were determined in ileal tissue and plasma using a
commercially available assay (Glutathione Assay Kit II, Merck
Chemicals, Hull, United Kingdom). To ensure absence of
adherent bacteria, samples were flushed with cold Kreb’s buffer,
and microscopically examined. Freeze-dried ileal mucosa was
homogenized in acid medium (0.2 M 2-(N-morpholino) ethane-
sulphonic acid, 0.05 M phosphate, and 1 mM EDTA, pH 6.0),
centrifuged (10 min, 10,0006g) and supernatants were collected.
After protein determination, supernatants corresponding with
1 mg protein, and plasma aliquots were deproteinized with 5%
metaphosphoric acid (Sigma-Aldrich Chemie BV) and 4 M
triethanolamine (Sigma-Aldrich Chemie BV) and plasma samples
were lyophilized.
Individual bacterial strains from the used probiotics were grown
in de Man-Rogosa-Sharpe (MRS) broth at 37uC for 24 h, under
strict anaerobic conditions. To determine GSH release during
bacterial growth, samples were taken at 0, 6, and 24 h, centrifuged
Probiotics Maintain Barrier
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(4,0006g for 10 min at 4uC) and supernatants were collected. For
determination of bacterial GSH content, bacteria were collected
after 24 h of cultivation and disrupted by sonication (Bransonic
3200, Branson Ultrasonics b.v., Soest, the Netherlands) on ice for
10 min with 3 sec cooling interval per min. Suspensions were
centrifuged, yielding a cell-free extract.
Cell-free extracts, tissue supernatants and plasma samples were
analyzed for total GSH according to the protocol provided by the
manufacturer. To quantify oxidized GSH (GSSG), 2-vinylpyridine
was added to the acidic medium to derivatize GSH. GSH levels
were calculated by subtracting the amount of GSSG from the total
GSH content and normalized to protein content.
Cysteine
Mucosal cysteine was determined using the spectrophotometric
method developed by Gaitonde [33] and expressed as nmol/mg
protein.
Glutamate-cysteine-ligase
Biosynthesis of GSH was analyzed by quantification of
glutamate-cysteine-ligase (GCL, EC: 6.3.2.2) activity as previously
described [34]. For determination of systemic GSH biosynthesis,
erythrocytes were obtained by centrifugation of ETDA blood
samples at 9006g for 3 min and after washing 3 times with 5
volumes of cold isotonic NaCl solution. Erythrocytes were lysed by
the addition of 50 mmol Tris-HCl buffer (pH 7.4), containing
1 mmol EDTA, and by sonication for 2620 seconds. The
erythrocyte membranes were removed by centrifugation at
18,0006g for 40 min. For determination of local intestinal
mucosal GCL activity, ileal tissues were homogenized in
250 mM sucrose containing 20 mM Tris, 1 mM EDTA, 20 mM
boric acid, 2 mM serine, pH 7.4. GCL activity was determined as
the difference between c-glutamylcysteine (GC) synthesis in
unblocked and GC synthesis in samples blocked with 200 mM
5-sulfosalicylic acid dehydrate and expressed as nmol (GC)/min/
mg protein.
mRNA expression analysis
Total RNA was isolated from ileal mucosa using the RNeasy
Midi Kit (Qiagen, Hilden, Germany) and spectrophotometrically
quantified, showing A260/A280 ratios within normal range.
Subsequently, the integrity of total RNA was checked by
denaturing agarose gel electrophoresis. First strand cDNA was
synthesized from total RNA using the iScript cDNA synthesis kit
(BioRad, Hercules, CA, USA) and quantitative RT-PCR was
performed using the iCycler iQ system (BioRad). RT-PCR with
mRNA-specific primers for the catalytic (GCLC) and modifier
(GCLM) subunits of GCL and 18S rRNA as a reference gene was
performed (GCLC-forward 59-ggcgatgttcttgaaactctg-39, GCLC-
reverse 59-cagagggttgggtggttg-39; GCLM-forward 59-ctgactcacaat-
gacccaaaag-39, GCLM-reverse 59-ttcaatgtcagggatgctttc-39; 18S
rRNA-forward 59-aatcagttatggttcctttgtcg-39, 18S rRNA-reverse
59-gctctagaattaccacagttatccaa-39; Sigma-Aldrich) and mRNA lev-
els were quantified using SYBR Green based detection.
Prior to real-time PCR analysis cDNA samples were diluted
1:25, except for 18S rRNA which was diluted 1:1000, with RNase-
free water. PCR reactions were set up in a volume of 25 ml,
containing 5 ml of diluted cDNA, 12.5 ml of 26 iQ SYBR Green
Supermix (BioRad) and 300 nM of the forward and reverse
primer each. Thermal cycling conditions were 95uC for 3 min as
initial denaturation and enzyme-activating step followed by 40
cycles of 95uC for 15 s denaturation, 60uC for 30 s annealing and
72uC for 30 s extension. After amplification a melting curve
analysis was performed by increasing the temperature by 0.5uC
increments from 55uC to 95uC and measuring fluorescence at
each temperature for a period of 10 s. All cDNA samples were
analyzed in triplicate and each run contained a relative standard
curve. Purified PCR products were used to generate the relative
standard curves, consisting of serial dilutions. Levels of GCLC and
GCLM mRNA were quantified using the comparative threshold
cycle method, normalized to18S rRNA expression and expressed
as ratio to controls (a.u.).
Statistical Analysis
Normal distribution was assessed using Shapiro–Wilk’s test.
Parametric values are presented as mean (SD). Statistical analysis
was performed by ANOVA followed by Tukey’s HSD test. Non-
parametric values are given as median (25–75th interquartile
range). Comparisons between two groups were done by Mann-
Whitney U-test and between multiple groups by Kruskal-Wallis.
Spearman’s rank correlation coefficients were computed for
correlation analyses. Considering Bonferroni’s correction,
P,0.01 was considered significant.
Results
Acute pancreatitis induced severe ileal mucosal barrier
dysfunction
Mortality due to AP did not occur. Pancreatitis was confirmed
by histological scoring of pancreatic injury [32] (sham-operated 0
(0-0) vs. after induction of pancreatitis 3 (2–5.1); P,0.001).
Pancreatitis induced increased permeability to HRP and 51Cr-
EDTA (fig 2A, B), accompanied by increase in baseline
conductance, representing paracellular ion flux (fig 2C) and
elevation of Isc, indicative of ion secretion (fig 2D). Moreover,
transepithelial bacterial passage increased by as much as 7-fold in
animals subjected to AP (fig 2E) and tissues from rats in the
pancreatitis group responded to E. coli K12 added to the luminal
buffer with an enhanced elevation in conductance (fig 2F). These
data suggest a combined perturbation of paracellular and
transcellular pathways.
To further characterize the paracellular pathway TJ protein
expression was studied in tissue sections. In sham-operated
animals, occludin was localized in the cytoplasm of epithelial cells
and along the basolateral membrane with an enrichment of
occludin at the apical surface (fig 3). In AP partial disruption of
occludin was seen in crypts as well as in villi. Claudin-1 staining
pattern was diffuse with predominantly intracellular localization in
sham-operated animals (fig 3). AP caused decreased staining
intensity and aggregation of claudin-1 within the cytosol. Claudin-
1 was not detected near areas of epithelial disruption, suggesting
that detachment of enterocytes was preceded by loss of claudin-1.
Contrary to occludin and claudin-1, the pore-forming TJ protein,
claudin-2 [7], was only scarcely detectable in crypts of sham-
operated animals, whereas rats from the AP group showed intense
staining of claudin-2 both in crypt and surface epithelium (fig 3).
It is reported that intestinal epithelial apoptosis contributes to
mucosal barrier dysfunction [9–11]. Confocal microscopy with
immunofluorescent TUNEL staining (fig 4A) revealed AP-induced
epithelial cell apoptosis compared to sham animals (25.8 (24.4–
26.3) vs. 2.60 (2.47–2.73) TUNEL+cells/100 epithelial cells;
P,0.001). Mucosal DNA-fragmentation corroborated these find-
ings (fig 4B). Moreover, DNA-fragmentation strongly correlated
with bacterial passage (fig 4C), 51Cr-EDTA flux (r = 0.93) and
tissue conductance (r = 0.87), which supports the hypothesis that
epithelial cell apoptosis disrupts barrier integrity.
Six hours after induction of pancreatitis, intestinal injury (fig 5A)
was characterized by villus denudation, lamina propria disinte-
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Figure 2. Probiotics prevented acute pancreatitis-induced ileal permeability but not ion secretion. After 5 days of pre-treatment with
placebo (pla, n = 12) or probiotics (pro, n = 12), rats were subjected to acute pancreatitis (AP, n = 12), a sham-procedure (n = 12) or not operated
(control, n = 5). Ileal segments were mounted in Ussing chambers and (A) horseradish peroxidase (HRP) and (B) 51Cr-EDTA flux were studied for two
hours. (C) Baseline conductance, (D) baseline short circuit current (Isc), (E) passage of Escherichia coli K12 and (F) elevation of conductance during one
hour after challenge with E. coli were measured. The graphs show average (6SD). The data were collected from independently acquired sets of 3
tissue segments per rat. Comparisons were performed using ANOVA followed by Tukey’s HSD.
doi:10.1371/journal.pone.0004512.g002
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gration and ulceration (fig 5B), resembling intestinal ischemia-
reperfusion injury [31], which is associated with ROS release,
epithelial apoptosis and TJ disruption [5,6,8]. Therefore, oxidative
stress-induced lipid peroxidation was quantified, which was indeed
found to be elevated after induction of AP (fig 5C) and also showed
a strong positive correlation with barrier dysfunction (51Cr-EDTA
flux r = 0.83, bacterial passage r = 0.88).
Probiotics prevented acute pancreatitis-induced barrier
dysfunction
No rats receiving probiotics showed signs of diarrhea or loss of
appetite during the pre-treatment period. Increase in animal
weight was similar in all groups (sham-operated 22.3 (1.09) vs. AP
21.9 (1.11) vs. placebo 20.6 (0.82) vs. probiotics 20.5 (0.61)). Five
days of pre-treatment with probiotics abolished the deleterious
effects of AP on numerous parameters of barrier function. AP-
induced increase in ileal permeability to HRP (fig 2A) and 51Cr-
EDTA (fig 2B) as well as tissue conductance (fig 2C) was
normalized after probiotic pre-treatment. Elevation in tissue
conductance after adding E.coli K12 was 40% smaller in tissues
from probiotic treated rats compared to placebo (fig 2F). In
contrast, there were no inhibitory effects of probiotics on AP-
induced elevation of Isc (fig 2D).
Probiotics also modified the localization of TJ proteins. AP-
associated partial disruption of the distribution of occludin in
crypts and villi was prevented and redistribution to the apical
surface was apparent in crypts of probiotic treated animals (fig 3).
In both claudin-1 and -2 staining patterns the AP-induced
deleterious effects were reduced by probiotic pre-treatment (fig 3).
Furthermore, probiotics attenuated AP-induced epithelial cell
apoptosis, showing a 70% reduction in apoptotic rate (8.85 (8.60–
9.15) vs. placebo 31.75 (31.60–32.90) TUNEL+ cells/100 epithelial
cells; P,0.001, fig 4A), which was also demonstrated by analysis of
mucosal DNA-fragmentation (fig 4B). Histological scoring dem-
onstrated that probiotics ameliorated pancreatitis-induced muco-
sal damage (1.0 (1.0–1.25) vs. placebo 4.0 (4.0-4.0); P,0.001,
fig 5A) and normalized mucosal lipid peroxidation (fig 5C).
Beneficial effect of probiotics by increasing mucosal
glutathione
The decline in mucosal lipid peroxidation after probiotic pre-
treatment may have resulted from either reduced amounts of
ROS, or enhanced antioxidative capacity. Therefore, we quanti-
fied mucosal oxidized glutathione (GSSG) and GSH in thoroughly
rinsed ileal mucosal tissues. Probiotics attenuated AP-induced
elevation in GSSG (fig 6A), prevented depletion of mucosal GSH
(fig 6B) and normalized the GSH/GSSG ratio (fig 6C). Of note,
mucosal GSH/GSSG ratios showed an inverse correlation with
DNA-fragmentation (fig 6D) and mucosal barrier dysfunction
(fig 6E, F). Most interestingly, pre-treatment with probiotics
induced increased levels of GSH, also in comparison with healthy
control animals (fig 6B).
Production of glutathione by the individual probiotic
strains
Since mucosal GSH is partially dependent on uptake of dietary
GSH [35], we quantified intrabacterial GSH of the separate
probiotic strains, as well as GSH levels in medium after 6 and
Figure 3. Probiotics prevented disruption of tight junction proteins. After 5 days of pre-treatment with placebo (pla) or probiotics (pro), rats
were subjected to acute pancreatitis (AP), or a sham-procedure. Ileal sections were stained with occludin, claudin-1 or -2 antibodies (green),
counterstained with DAPI (blue) and visualized by confocal laser scanning microscopy. Bar = 500 mm. The higher magnification (1006/1.30) images
shown in the insets are typical details of crypts (left) and villi (right). Probiotics prevented the deleterious effects of AP on occludin and caused
redistribution of occludin to the apical surface (arrowhead). Acute pancreatitis-induced detachment of epithelial cells seems to be preceded by loss of
claudin-1 (arrowhead) and was reduced by probiotic pre-treatment; though probiotics could not prevent the AP-induced formation of aggregates of
claudin-1 in the cytosol (arrowhead). Probiotics prevented AP-associated up-regulation of claudin-2 in both crypts and villi (arrowhead). The patterns
of staining are typical of that seen in 4 sections of 4 rats per group.
doi:10.1371/journal.pone.0004512.g003
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24 hours of strictly anaerobic cultivation. Only B. bifidum, B. lactis
and L. acidophilus contained abundant intracellular GSH (Table 1).
GSH in cultivation medium increased over time, except for Lc.
lactis.
Local mucosal biosynthesis of glutathione
Mucosal GSH is, besides dietary uptake, also dependent on
biosynthesis, which is regulated by availability of cysteine and
GCL activity [36]. Mucosal cysteine levels did not differ
significantly between the groups (fig 7A). GCL activity, however,
was affected by AP and by probiotics pre-treatment. AP per se
increased GCL activity compared to sham, but the most abundant
increase was seen in the probiotics group which showed a 10-fold
increase compared to controls (fig 7B).
Because GCL is composed of both a catalytic and modulatory
subunit [37], the increase in GCL activity in this study could be due
to enhanced expression of either GCLm and/or GCLc. Therefore,
quantitative real-time PCR was performed to monitor changes in
GCLc and GCLm message abundance. The level of mRNA
expression of the reference gene, 18S, was comparable between all
groups. When normalized to 18S, GCLc levels in probiotic pre-
treated rats were 6.78 (0.95) a.u., which was 1.8 fold higher than in
placebo treated rats (3.83 (0.49) a.u., fig 7C, D). Similarly, levels of
GCLm mRNA after probiotic pre-treatment (10.3 (2.56) a.u) were
2.7 fold higher than average values seen in placebo treated rats (3.88
(0.75) a.u). The increase in GCLm mRNA expression was less
pronounced in the AP and placebo groups when compared to sham
operated animals (3.07 vs. AP 4.68 a.u.; 3.07 vs. placebo 3.88 a.u.,
respectively, fig 7C, E). These data suggest that the enhanced GCL
activity after probiotic pre-treatment may be due to increased gene
expression in the ileal mucosa.
Probiotics increase systemic glutathione levels
To gain insight into the antioxidative capacity prior to induction
of AP, plasma GSH levels before treatment, before induction of
AP and at time of termination were determined. In the course of
the 5 days of the pre-treatment period, plasma GSH levels showed
a 2 fold increase in probiotic pre-treated animals (fig 8A). This was
in contrast to rats receiving placebo, in which plasma GSH levels
did not differ significantly after 5 days of pre-treatment. This is in
keeping with the increase in GCL activity in red blood cells (RBC)
after 5 days of pre-treatment with probiotics (fig 8B). Correlation
analyses between pancreatitis-induced oxidative damage, as
measured by ileal lipid peroxidation and GCL activity immedi-
ately before induction of pancreatitis, suggested that GCL activity
greater than 5 nmol/min/mg protein was protective against
oxidative injury (fig 8C). Furthermore, GCL activity in RBCs
immediately before induction of acute pancreatitis correlated
inversely with parameters of mucosal barrier dysfunction in
animals subjected to AP (bacterial passage: r =20.80, 51Cr-
EDTA: r =20.86, fig 8D, E). Not surprisingly, GCL activity also
correlated positively with ileal GSH levels in animals subjected to
AP (r = 0.82, fig 8F).
Discussion
The present study is the first to demonstrate that pre-treatment
with multispecies probiotics increases mucosal GSH levels and
stimulates GSH biosynthesis in the ileum, resulting in attenuated
oxidative mucosal damage. Furthermore, normalization of GSH/
GSSG ratios strongly correlated with improved barrier function.
Therefore, increased mucosal GSH levels represent a candidate
mechanism underlying the protection against barrier dysfunction
afforded by pre-treatment with probiotics in experimental AP.
Figure 4. Probiotics reduced pancreatitis-associated intestinal
apoptosis. After 5 days of pre-treatment with placebo or probiotics,
rats were subjected to acute pancreatitis, or a sham-procedure. (A)
Sections of ileum were TUNEL stained. The results shown are typical
images from 4 sections of 4 rats per group. Bar = 200 mm. (B) DNA-
fragmentation (control n = 5, sham n= 12, AP n= 12, AP pla n = 12 and
AP pro n= 12). The graph shows the average (6SD). Comparisons were
performed using ANOVA followed by Tukey’s HSD. (C) Positive
correlation between intestinal apoptosis and Escherichia coli K12
passage was computed using Spearman’s rank correlation coefficients.
doi:10.1371/journal.pone.0004512.g004
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GSH synthesis was up-regulated in probiotic pre-treated rats, as
demonstrated by enhanced GCL activity and increased mRNA
expression of both of the GCL subunits, shown herein. GSH plays
a pivotal role in maintenance of the redox balance (expressed as
GSH/GSSG ratios), preventing oxidative damage [4] and
maintaining mucosal barrier, which was reflected by the inverse
correlation between mucosal GSH/GSSG ratios and parameters
of barrier dysfunction. Two factors directly associate with mucosal
GSH: dietary GSH levels [35] and GSH biosynthesis, of which the
latter is in turn dependent on cysteine availability and GCL
activity [36]. First, it has been reported that certain probiotics
contain and release GSH [20,38,39] and Peran et al. [20]
previously showed increased intestinal GSH following oral
administration of Lactobacillus fermentum in experimental colitis.
Our present in vitro experiments showed strain specific differences
in intracellular GSH content within the range previously reported
[38]. Moreover, time-dependent GSH release was found during
anaerobic cultivation, which was abundant in B. bifidum, B. lactis
and L. acidophilus. Nevertheless, considering an estimated GSH
production of 31.0 nmol GSH by the total administered probiotic
dose (17.9 nmol intrabacterial GSH (mean 0.13 nmol GSH/mg
protein) +13.1 (1.53) nmol GSH secreted in 5 days; calculated
from Table 1) compared with an estimated total increase in small
intestinal GSH of 1190 nmol (small intestinal length 90 cm,
mucosal protein content 2.4 mg/cm (n= 6); pre-treatment yielded
increase in ileal GSH of 5.5 nmol/mg protein; placebo 8.8 vs.
probiotics 14.3 nmol/mg protein, fig 6B), bacterial GSH could
only partially account for the rise in ileal GSH content.
Consequently, the possibility of local GSH biosynthesis was
investigated. The present study did not show significant differences
in mucosal cysteine, implying that cysteine availability was not an
important discriminating factor. On the other hand, we found
enhanced GCL activity and expression of the GCL subunits GCLc
and GCLm in probiotic-treated animals leading to a significant
increase in GSH contents. Although the contribution from the
probiotic bacteria may be higher than calculated because of
colonization and expansion, it is conceivable that enhanced CGL
activity in the intestinal mucosa was the major factor contributing
to the increased ileal GSH content.
Interestingly, correlation analysis between GCL activity and
parameters of mucosal barrier failure in animals subjected to AP,
suggested the existence of a threshold GCL activity above which
mucosal protection against oxidative stress is functional. This may
explain that the relatively small increase in GCL activity between
the probiotic and the placebo pre-treated groups resulted in
considerable protection, whereas the rise in GCL activity between
the sham and the AP group did not ameliorate the AP-induced
damage. This hypothesis is supported by the correlation between
GCL activity and ileal GSH content; the latter was only above a
certain threshold of GCL activity able to withstand the deleterious
effects of AP.
As previous experimental studies have shown that GCL gene
expression is up-regulated both after low dose H2O2 [17] and after
Figure 5. Probiotics attenuated acute pancreatitis-associated
mucosal damage. After 5 days of pre-treatment with placebo (pla,
n = 12) or probiotics (pro, n = 12), rats were subjected to acute
pancreatitis (AP, n = 12), or a sham-procedure (n = 12). (A) Sections of
ileum were H&E stained and graded according to Chiu et al. (25). The
graph shows median (6range). Comparisons were performed using
Kruskal-Wallis followed by Mann–Whitney U test. (B) Compared with
sham-operated animals (Sham), acute pancreatitis (AP) caused wide-
spread destruction of villi. Placebo treated animals (AP pla) also showed
a severe degree of mucosal damage. Probiotic animals (AP pro) showed
extensive epithelial lifting, but with intact epithelium. The mucosal
damage is typical of that seen in 4 sections from 12 rats per group.
Bar = 200 mm. (C) Lipid peroxidation (MDA levels) (control n = 5, sham
n= 12, AP n= 12, AP pla n = 12 and AP pro n= 12). The graph shows the
average (6SD). Comparisons were performed using ANOVA followed by
Tukey’s HSD.
doi:10.1371/journal.pone.0004512.g005
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administration of weak inducers of oxidative stress [18], the
increase in GCL activity found in the present study could be
indicative of cellular stress as a mechanistic factor. Administration
of probiotics may have caused a minor oxidative assault, e.g.
intracellular accumulation of short-chain fatty acids produced by
the bacteria, thereby inducing increased capacity of antioxidant
enzymes, preconditioning the mucosa for a major oxidative attack
during AP. This hypothesis is further supported by the found
increase in systemic GCL activity in the probiotic pre-treated
group, which was markedly enhanced already before the induction
of AP. At first glance, it may seem contradictory to the current
study that the recent placebo-controlled trial by Besselink et al.
Figure 6. Probiotics enhanced mucosal glutathione levels. After 5 days of pre-treatment with placebo (pla, n = 12) or probiotics (pro, n = 12),
rats were subjected to acute pancreatitis (AP, n = 12), a sham-procedure (n = 12) or not operated (control, n = 5). Six hours after induction of the AP or
sham-procedure, mucosal (A) oxidized glutathione levels (GSSG), (B) reduced glutathione levels (GSH) and (C) GSH/GSSG ratios were determined. The
graphs show average (6SD). Comparisons were performed using ANOVA followed by Tukey’s HSD. Correlation analyses revealed an inverse
correlation between GSH/GSSG ratio and (D) DNA-fragmentation, (E) ileal permeability to Escherichia coli K12 and (F) 51Cr-EDTA flux. Spearman’s rank
correlation coefficients were computed for correlation analyses.
doi:10.1371/journal.pone.0004512.g006
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[24], demonstrated increased incidence of bowel ischemia after
administration of probiotics in the acute phase of severe AP.
However, keeping in mind that enteral probiotics caused low dose
oxidative stress, probiotics administered after the onset of AP may
act as an extra oxidative burden in an already critically affected
redox system [3] thereby, causing increased oxidative stress-
induced damage and ischemia.
During critical illness oxidative stress disrupts TJs [5,6], which are
crucial in determining epithelial barrier properties [7], as illustrated
here by the AP-induced breach in barrier function. Disruption of TJs
results in increased permeability to luminal antigens and bacteria that
promote release of pro-inflammatory cytokines which further
deteriorates mucosal barrier function [2]. This is in keeping with
our results that are the first to show AP-induced disruption of the
claudin-1 distribution together with up-regulation of claudin-2, which
is also the case in inflammatory bowel disease and destabilizes TJs
[7,10,40]. Immunostaining revealed that pre-treatment with probio-
tics maintained TJ integrity with a normal distribution of claudin-1
and -2. The finding of Yasuda and colleagues [9], that AP did not
have deleterious effects on occludin, is in contrast with our results. This
may, however, be explained by differences in the model of AP used.
Apoptosis is the major mode of cell death during intestinal
ischemia/reperfusion [8] and exerts deleterious effects on mucosal
barrier function and survival [9–11,13,14]. Yan et al. [41]
previously showed that soluble proteins produced by Lactobacillus
strains protect epithelial cells from cytokine-induced apoptosis.
Here, we found that probiotics, which induced GSH biosynthesis,
normalized AP-induced epithelial cell apoptosis. In addition, we
were able to demonstrate a positive correlation between mucosal
DNA-fragmentation and barrier dysfunction, providing further
evidence that oxidative stress plays an important role in induction
of epithelial apoptosis and subsequent loss of barrier function.
Contrary to the effects on permeability, pre-treatment with
probiotics showed no effect on ion secretion in our experiment.
These findings emphasize the divergent regulation of cellular
secretory and barrier functions. It has been reported that epithelia
respond rapidly to pathogenic bacteria with altered ion secretion
[42], indicating that ‘‘flushing out’’ may be a defense mechanism
against the threat of invasion of the mucosa. In this regard, it is
perhaps advantageous that probiotics do not inhibit these
beneficial adaptive responses to an infectious threat.
In conclusion, the present study is to our knowledge the first to
show that pre-treatment with multispecies probiotics, stimulates
mucosal GSH biosynthesis and consequently normalizes AP-
induced barrier dysfunction and attenuates epithelial cell apoptosis
and disruption of TJs in a model of AP. In addition, our data
demonstrate strong inverse correlations between mucosal GSH/
GSSG ratios and mucosal barrier dysfunction. This further supports
the functional relevance of this endogenous antioxidant and gives
novel insights into the mechanisms of probiotics. However, as the
used compound is a multispecies combination of probiotic strains, it
is worth noting that the found effects depend on the combination of
the applied bacteria. Additional studies will be necessary to
elucidate the effects of each separate strain as well as possible
synergistic effects of this specific combination of probiotics.
In addition, the role of oxidative stress has been evaluated in
experimental models of acute pancreatitis [43] and it should be
emphasized that oxidative stress and excessive ROS generation
are early features in AP and consequently a difficult target for
clinical prophylaxis to prevent a severe course of the disease. This
has recently been shown in a randomized controlled trial, utilizing
intravenous antioxidant (n-acetylcysteine, selenium, vitamin C)
therapy, where the results in AP patients were not that
encouraging [44]. However, oxidative stress is not only involved
in the early stage of AP, but also in the course of the disease and
may for that reason be a target for therapy at later stages of the
disease. However, as the probiotics used in the current study
showed severe adverse effects in intensive care AP patients [24],
and since the present effects on GCL activity most likely resulted
from a mild oxidative stress, this combination of probiotics is not a
defendable treatment option in critically ill patients. Therefore, the
appropriate clinical use of multispecies probiotics would be a
preventive approach to improve defense against an expected
oxidative attack, such as before elective major abdominal surgery
[45] or maintenance treatment in IBD and pouchitis [46,47].
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Table 1. Intracellular GSH contents of the probiotic strains and GSH levels in medium at different time points after start of
cultivation.
Bacterial strain Intracellular GSH (nmol/mg protein) GSH content in culture medium (nmol/ml supernatant)
0 hour 6 hours 24 hours
B. bifidum W23 0.37 (0.002) 0.00 (0.000) 0.10 (0.006) 0.51 (0.006)
L. salivarius W24 0.11 (0.002) 0.00 (0.000) 0.08 (0.004) 0.15 (0.006)
B. lactis W52 0.01 (0.002) 0.00 (0.000) 0.00 (0.000) 0.01 (0.008)
L. casei W56 0.09 (0.004) 0.00 (0.000) 0.00 (0.000) 0.01 (0.002)
Lc. lactis W58 0.04 (0.014) 0.00 (0.000) 0.00 (0.000) 0.00 (0.000)
L. acidophilus W70 0.14 (0.005) 0.00 (0.000) 0.04 (0.002) 0.19 (0.002)
Bifidobacterium (B.); Lactobacillus (L.); Lactococcus (Lc.); glutathione (GSH).
Mean (SD), n = 4 separate experiments.
doi:10.1371/journal.pone.0004512.t001
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Figure 7. Probiotics have no effect on cysteine availability, but induce glutamate-cysteine-ligase activity. After 5 days of pre-treatment
with placebo (pla, n = 12) or probiotics (pro, n = 12), rats were subjected to acute pancreatitis (AP, n = 12), a sham-procedure (n = 12) or not operated
(control, n = 5). Six hours after induction of the AP or sham-procedure, tissue cysteine availability (A) and mucosal glutamate-cysteine-ligase (GCL)
activity (B) were determined in ileum samples. (C) RT-PCR was conducted on ileal mRNA. PCR products of specific primers for the catalytic (GCLc,
65 bp) and the modulatory (GCLm, 81 bp) subunit of GCL and for 18S rRNA (65 bp) as control were identified on 2.5% agarose gel, using a GeneRuler
50 bp DNA Ladder (Fermentas GMBH, St. Leon-Rot, Germany). mRNA expression of (D) GCLc and (E) GCLm were quantified. Data are normalized to
18S rRNA expression and expressed as ratio to control animals. The graphs show average (6SD). All analyses were run in triplicates. Comparisons
were performed using ANOVA followed by Tukey’s HSD.
doi:10.1371/journal.pone.0004512.g007
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Figure 8. Probiotics induce systemic increase in GSH levels and GCL activity. After 5 days of pre-treatment with placebo (pla, n = 12) or
probiotics (pro, n = 12), rats were subjected to acute pancreatitis (AP, n = 12), a sham-procedure (n = 12) or not operated (control, n = 5). Whole blood
was sampled 1) before treatment, 2) after 5 days of pre-treatment, immediately before induction of AP and 3) six hours after induction of AP or sham-
procedure. Time course of plasma GSH levels (A) and GCL activity in red blood cells (B) was monitored. The graphs show average (6SD). All analyses
were run in duplicates. Comparisons were performed using ANOVA followed by Tukey’s HSD. *P,0.001, probiotics vs. placebo. Associations between
(C) ileal lipid peroxidation, (D) bacterial passage, (E) 51Cr-EDTA flux, (F) ileal GSH content six hours after induction of AP and GCL activity in red blood
cells immediately before subjection to AP.
doi:10.1371/journal.pone.0004512.g008
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